Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
36.77
+0.25 (0.68%)
At close: Aug 14, 2026, 4:00 PM EDT
36.75
-0.02 (-0.05%)
After-hours: Aug 14, 2026, 7:50 PM EDT
Teva Pharmaceutical Market Cap
Teva Pharmaceutical has a market cap or net worth of $42.85 billion as of August 14, 2026. Its market cap has increased by 117.03% in one year.
Market Cap
42.85B
Enterprise Value
56.09B
1-Year Change
117.03%
Ranking
Category
Stock Price
$36.77
ChartMarket Cap Chart
Since December 1, 1998, Teva Pharmaceutical's market cap has increased from $6.10B to $42.85B, an increase of 602.21%. That is a compound annual growth rate of 7.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 42.85B | 19.66% |
| Dec 31, 2025 | 35.81B | 43.39% |
| Dec 31, 2024 | 24.97B | 113.39% |
| Dec 29, 2023 | 11.70B | 15.54% |
| Dec 30, 2022 | 10.13B | 14.65% |
| Dec 31, 2021 | 8.84B | -16.46% |
| Dec 31, 2020 | 10.58B | -1.18% |
| Dec 31, 2019 | 10.70B | -31.87% |
| Dec 31, 2018 | 15.71B | -18.33% |
| Dec 29, 2017 | 19.23B | -41.54% |
| Dec 30, 2016 | 32.90B | -41.16% |
| Dec 31, 2015 | 55.92B | 2.69% |
| Dec 31, 2014 | 54.45B | 43.98% |
| Dec 31, 2013 | 37.82B | 7.52% |
| Dec 31, 2012 | 35.17B | -7.04% |
| Dec 30, 2011 | 37.84B | -21.40% |
| Dec 31, 2010 | 48.14B | -3.59% |
| Dec 31, 2009 | 49.93B | 45.08% |
| Dec 31, 2008 | 34.41B | -6.66% |
| Dec 31, 2007 | 36.87B | 83.46% |
| Dec 29, 2006 | 20.10B | -25.46% |
| Dec 30, 2005 | 26.96B | 62.59% |
| Dec 31, 2004 | 16.58B | 13.05% |
| Dec 31, 2003 | 14.67B | 46.88% |
| Dec 31, 2002 | 9.99B | -51.34% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical Company | 55.70B |
| Haleon | 42.55B |
| Zoetis | 31.34B |
| United Therapeutics | 21.50B |
| Viatris | 18.42B |
| Neurocrine Biosciences | 15.33B |
| Elanco Animal Health | 11.25B |
| Dr. Reddy's Laboratories | 10.53B |